跳至主要内容
临床试验/NCT03921788
NCT03921788已完成不适用

Study of the Role of Vasoactive Neuropeptides in the Genesis of Venous Pelvic Pain

Pirogov Russian National Research Medical University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
The severity of venous pelvic pain

研究概览

简要总结

Mechanisms of the development of pain in chronic venous diseases (CVD), including pelvic congestion syndrome (PCS), are studied incompletely. The existing hypotheses of the occurrence of venous pelvic pain (VVP) do not allow to answer the question why some patients have no pain syndrome while others have very pronounced pain despite the same morphofunctional changes in the pelvic veins? The investigators are planning to carry out a study aimed at studying the content of calcitonin gene-related peptide (CGRP) and substance P (SP) in the serum of patients with pelvic veins and pelvic pain, and to study the relationship between the values of CGRP and SP in these patients.

详细描述

The first phase of the study includes a set of 3 patient groups: the first is patients with pelvic vein dilation and blood reflux through them in combination with venous pelvic pain; the second is patients with pelvic vein dilatation without venous pelvic pain. The third, control group will include healthy female volunteers without pelvic veins and any chronic pain syndromes.

At the second stage of the study, a study will be made of the levels of calcitonin gene-related peptide (CGRP) and the substance P (SP) in the serum using an ELISA method. In addition, after studying the content of the CGRP and SP in the serum of volunteers, the investigators expect to obtain the reference values of these neuropeptides. In this phase of the study, a statistical analysis of the data obtained will be carried out, a correlation analysis between venous pelvic pain and the level of the CGRP and CP.

The data for each patient will be entered into a specially designed patient questionnaire. It will include clinical and ultrasound data, results of ELISA.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • The reproductive age of the woman
  • Blood reflux in the parametric, uterine, gonadal veins
  • The absence of any concomitant pathology, accompanied by chronic pelvic pain

排除标准

  • The absence of blood reflux in in the parametric, uterine, gonadal veins
  • The presence of diseases, the clinical course of which suggests the presence of chronic pelvic pain and other varieties of chronic pain, including migraine
  • Pregnancy

结局指标

主要结局

The severity of venous pelvic pain

时间窗: 5 min

For the quantitative determination of the severity of venous pelvic pain using a visual analogue scale, measurement in points. The visual analogue scale (VAS) consists of a straight line with the endpoints defining extreme limits such as "no pain at all" and "pain as bad as it could be". The patient is asked to mark his pain level on the line between the two endpoints. The distance between "no pain at all" and the mark then defines the subject's pain.

The level of calcitonin-gene-related peptide

时间窗: 22 hours

Protocol V (Ab1hr.Std2hr. BtON) was used for the enzyme-linked immunosorbent assay (ELISA). The indicator is measured in ng / ml

The level of substance P

时间窗: 22 hours

Protocol V (Ab1hr.Std2hr. BtON) was used for the enzyme-linked immunosorbent assay (ELISA). The indicator is measured in ng / ml

次要结局

未报告次要终点

研究者

发起方
Pirogov Russian National Research Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sergey Gavrilov, MD, PhD

Professor of the Department of Faculty Surgery №1

Pirogov Russian National Research Medical University

研究点 (1)

Loading locations...

相似试验